Brent Warner serves as Executive at Poseida Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Brent Warner has executed 5 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Mar 1, 2024 involved receiving (via award) 80,743 shares valued at $0.
Brent Warner currently holds 454,779 shares of Poseida Therapeutics, Inc. (PSTX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Brent Warner has been a net neutral trader of PSTX stock. They have purchased $0 and sold $0 worth of shares.
Brent Warner's most recent insider trade was on Mar 1, 2024, when they sold 80,743 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $4.13 |
| Discretionary |
| Mar 1, 2023 | PSTX | $142.4K | Payment | 26,617 | $5.35 | Discretionary |
| Mar 1, 2023 | PSTX | $0 | Award | 92,772 | $N/A | Discretionary |
| Mar 1, 2022 | PSTX | $0 | Award | 307,881 | $N/A | Discretionary |